[HTML] cell.comFull View

[HTML][HTML] RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer

W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu… - Cancer cell, 2018 - cell.com
Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and
immunotherapeutic resistance. We discovered upregulation of receptor-interacting …
被引用次数：209 相关文章
[HTML] sciencedirect.com

[HTML][HTML] RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer

W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu… - Cancer Cell, 2018 - Elsevier
Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and
immunotherapeutic resistance. We discovered upregulation of receptor-interacting …

RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer

W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu… - 2018 - dukespace.lib.duke.edu
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Skip to Main ContentSkip to SearchSkip to First ResultSkip to FiltersSkip to Admin Sidebar Duke …

RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer.

W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu… - Cancer Cell, 2018 - europepmc.org
Pancreatic ductal adenocarcinoma (PDA) is characterized by immune-tolerance and
immunotherapeutic resistance. We discovered upregulation of receptor-interacting …

RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer

W Wang, JM Marinis, AM Beal, S Savadkar… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and
immunotherapeutic resistance. We discovered upregulation of receptor-interacting …
[HTML] nih.gov

[HTML][HTML] RIP1 Kinase Drives Macrophage Mediated Adaptive Immune Tolerance in Pancreatic Cancer

W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu… - Cancer cell, 2018 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDA) is characterized by immune-tolerance and
immunotherapeutic resistance. We discovered upregulation of receptor-interacting …
[HTML] cell.com

[HTML][HTML] RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer

W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu… - Cancer Cell, 2018 - cell.com
Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and
immunotherapeutic resistance. We discovered upregulation of receptor-interacting …

RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer.

W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu… - Cancer Cell, 2018 - europepmc.org
Pancreatic ductal adenocarcinoma (PDA) is characterized by immune-tolerance and
immunotherapeutic resistance. We discovered upregulation of receptor-interacting …